Tonix Pharmaceuticals Holding Corp. (TNXP)

14.12 +0.54 (+3.94%) USD  |  NASDAQ  |  Aug 31, 16:00
14.12 0.00 (0.00%) After-Hours: 20:00
More

Tonix Pharmaceuticals Cash and Short Term Investments (Quarterly) : 176.23M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TNXP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 176.23M
March 31, 2026 185.47M
December 31, 2025 207.64M
September 30, 2025 190.06M
June 30, 2025 125.33M
March 31, 2025 131.72M
December 31, 2024 98.78M
September 30, 2024 28.23M
June 30, 2024 4.156M
March 31, 2024 7.049M
December 31, 2023 24.95M
September 30, 2023 6.914M
June 30, 2023 25.62M
March 31, 2023 71.98M
December 31, 2022 120.23M
September 30, 2022 139.98M
June 30, 2022 176.98M
March 31, 2022 140.44M
December 31, 2021 178.66M
September 30, 2021 182.97M
June 30, 2021 165.72M
March 31, 2021 164.21M
December 31, 2020 77.07M
September 30, 2020 55.66M
June 30, 2020 55.02M
Date Value
March 31, 2020 30.66M
December 31, 2019 11.25M
September 30, 2019 10.02M
June 30, 2019 12.15M
March 31, 2019 16.45M
December 31, 2018 25.03M
September 30, 2018 14.77M
June 30, 2018 16.77M
March 31, 2018 19.25M
December 31, 2017 25.50M
September 30, 2017 29.31M
June 30, 2017 34.36M
March 31, 2017 22.42M
December 31, 2016 26.12M
September 30, 2016 26.74M
June 30, 2016 31.25M
March 31, 2016 27.49M
December 31, 2015 43.02M
September 30, 2015 55.05M
June 30, 2015 48.74M
March 31, 2015 58.18M
December 31, 2014 38.18M
September 30, 2014 46.23M
June 30, 2014 43.87M
March 31, 2014 49.55M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Exelixis, Inc. 839.38M
Inovio Pharmaceuticals, Inc. 36.67M
Heron Therapeutics, Inc. 42.66M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B